Vanderbilt Health researchers and colleagues have isolated human monoclonal antibodies from previously infected individuals ...

Researchers analyzed 44 Bundibugyo virus genomes and modeled how approved and experimental Ebola antibodies might bind the ...

Monoclonal antibodies help your immune system recognize and attack myeloma cells. These drugs are often helpful when other therapies don’t work, you have a recurrence, or you aren’t eligible for stem ...

Monoclonal antibodies (mAbs) have been a key therapeutic option for non-communicable diseases for decades, and a small number of mAbs have helped treat infectious diseases, including COVID-19. The ...

Monoclonal antibodies are laboratory-produced molecules that mimic the body's natural immune response. They are created by cloning a single type of immune cell, a plasma cell, to produce large ...

This article explores how advances in antibody engineering are moving immunotherapy beyond traditional monoclonal antibodies to bispecific and trispecific formats and logic-gated designs.

I n 2024, the U.S. Food and Drug Administration (FDA) approved the first monoclonal antibody for reducing food allergy reactions, including anaphylaxis, in adults and children age 1 year or older. The ...

Monoclonal antibodies provide protection against a wide range of infectious microbes, and now, in a series of elegant laboratory experiments, scientists have uncovered how a pair of these ...

Monoclonal antibodies—treatments developed by cloning a cell that makes an antibody—could help provide an answer to the growing problem of antimicrobial resistance, say scientists. A team lead by ...

For the first time this fall, families will be offered season-long protection for infants and some children against respiratory syncytial virus (RSV). The US Food and Drug Administration (FDA) in July ...

Scientists can circumvent these challenges and keep their research moving forward with Bio X Cell’s in vivo antibodies, which are formulated in preservative-free PBS, tested for pathogens and ...

A team from the Microbiology Department at the Icahn School of Medicine at Mount Sinai has discovered three powerful monoclonal antibodies from a person who had previously been infected with mpox ...